PROP vs REGN · rev $241.6M vs P/E 14, rev $14.34B
Prairie Operating Co. Common Stock (PROP) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Prairie Operating Co. Common Stock (PROP) is a oil & gas e&p company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported PROP revenue for 2025-12-31 was $241.6M. Net income was $32.1M. Revenue was up 2943.8% from 2024-12-31 to 2025-12-31. PROP currently screens at market cap $64.3M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
PROP currently screens at market cap $64.3M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the PROP and REGN stock pages for the full models.
Not investment advice.